Born in 1955, Frank was one of first Chinese entrepreneurs to invest in the real estate industry. Since 2015, Frank has been leading the Board to formulate the overall development strategy for HH Biotech. He was a Director of Shenyang Maryland International Industrial Co., Ltd. in 2008. Prior to that, Frank was the Chief Executive Officer of Great China International Holdings Company since 2005. From 1989 to 2005, He was the Chairman of Shenyang Maryland International Industrial Co., Ltd.
As the CEO and Director of HH Biotech since September 2016, Sheng has been focusing on executing the Company's growth strategy. From 2014 to 2016, Sheng was the Investor Relations Director of Great China International Holdings Company. Prior to that, Sheng was an International Marketing Director of Vantage Wines, a US-based wine company. Sheng graduated from University of California Davis in 2009 with a bachelor degree in Political Science.
Shuang has been the Secretary of the Board since September 2016, responsible for HH Biotech's investor relations and administrative management. Prior to that, Shuang was the CEO of Shenyang West Village Business Club & Lounge from 2009 to 2015. From 2003 to 2008, Shuang was a Vice President in G & G International Distribution Inc. in Toronto, Canada. From 1999 to 2002, Shuang is a Certified Financial Planner in AXA Advisors Financial Group in United States. Shuang holds a master degree from University of Houston in United States.
Charles T. Mathews is a former Deputy District Attorney for the County of Los Angeles who distinguished himself in the legal profession since being first admitted to practice in 1973.After that, he joined Texaco, Inc.’s legal staff as a trial lawyer and subsequently joined Coldwell Banker Commercial Brokerage Company as Regional Counsel. In 1980, Mr. Mathews entered private practice. His civil practice has focused on Wrongful Termination, Discrimination, Civil Rights, Business, Personal Injury, Real Estate and other areas of trial work. Mr. Mathews is admitted to practice beforeThe United States Supreme Court and is a member of The American Bar Association. He is a graduate of Loyola University and Loyola Law School in Los Angeles, California.
Ying has been the Independent Director and Chairman of Governance and Nomination Committee of HH Biotech since September 2016. Born in 1962, Ying is the founder of Kaiyi Food Co. Ltd., a supplier in the food industry in United States. Ying is also engaged in botany, plantation development, and the product processing industry. Ying has been the Chairman and President of the US One Bamboo Investment Management Company since 2007. From 2010 to 2012, Ying was the Dean of Business School and a member of the "Think Tank" at University of Chicago. From 1995 to 2014, Ying was the Chairman and Chief Executive Officer of Hongkong Far East Group. Ying was also the Chairman of Chairman of the Qingdao Kaiyi Food Co., Ltd., the Chiarman and President of U.S Kaiyi Food Co. Ltd. from 1993 to 2007. In 2005, Ying served as a Spokeswoman for the American Association of Food Seasoning. Ying was also a Honorary Director of University of Chicago from 2010 to 2014. Ying holds a master degree from Business School of University of Chicago.
Yizhao has been the Independent Director and Chairman of Audit Committee of HH Biotech since June 2016. Born in 1970, Yizhao is a CPA in the state of Delaware in United States, and a member of the American Institute of Certified Public Accountants (AICPA), as well as a member of the Chartered Global Management Accountant (CGMA). 1993-1999 in charge of investment portfolio management and asset trading in Guangdong Southern Financial Services Company.
Yizhao serves as an independent, non-executive director of Kaisa Group Holdings Limited (Hong Kong stock exchange code: 1638) and China Carbon Graphite Group (OTCBB:CHGI). Previously, he was affiliated with China Green Agriculture, Inc., China Education Alliance, Inc., Universal Travel Group, Energroups Holdings Corporation, Asia Media Co., Ltd, Shengtai Pharmaceutical Inc., Carson International Holdings Co., Ltd., China Natural Resources Incorporation and Chinawe Asset Management Corporation as a director or a senior management team member.
Yizhao holds a bachelor degree in Economics from Fudan University and an MBA degree in Financial Analysis and Accounting from State University of New York, Buffalo.
A wholly-owned Subsidiary founded in 1989 with the registered capital of RMB 41.5 million controlled through HK Silverstrand International Investment Holdings Company Limited. Shenyang Maryland has developed a large number of superior quality real estate projects and is one of the earliest private real estate development companies in China. The primary business of the company is self-owned property rentals and management, which serves as strong support for the development of the Group.
HH Biotechnology (China) Co., Ltd. is a wholly-owned Subsidiary of HHBT founded in 2016 with the registered capital of $15 million. The company has more than 10 experienced technical experts and operates main businesses including biotechnology R&D, technology & product transformation and sales in China.
HK Silverstrand International Investment Holdings Company Limited is a wholly-owned Subsidiary of HHBT founded in 2004 with the registered capital of HK$1,282 and wholly owned Shenyang Maryland International Industry Co., Ltd.
A holding Subsidiary of HHBT founded in 2015 with the registered capital of 50 million yen. The company’s main businesses includes biotechnology R&D, import-export trading and product sales in Japan.
A wholly-owned Subsidiary founded in 2016 with the registered capital of RMB 50 million (controlling through Shenyang Maryland International Industry Co., Ltd.). The main businesses of the company includes perilla planting, producing and processing.
A shareholding company of HHBT founded in 2014 with the registered capital of RMB 126.57 million. The company’s main businesses are macadamia nut planting, production and processing.
As the CEO and Director of HH Biotech since September 2016, Sheng has been
focusing on executing the Company's growth strategy. From 2014 to 2016,
Sheng was the Investor Relations Director of Great China
International Holdings Company. Prior to that, Sheng was an International
Marketing Director of Vantage Wines, a US-based wine company. Sheng
graduated from University of California Davis in 2009 with a bachelor
degree in Political Science.
Lirong has been the Chief Financial Officer of HH Biotech since September
2016, responsible for the financial planning and fund management of the
company. Previously, Lirong was a Director of Shenyang Maryland
International Industrial Co., Ltd from 2008 to 2016. From 2005 to 2008,
Lirong is the CFO of Great China International Holdings Company. From 1995
to 2008, Lirong is the CFO of Shenyang Maryland International Industrial
Co., Ltd. Lirong holds a bachelor degree in Senior Accountant.
Sasaki has been the Marketing Director of HH Biotech since September 2016. Sasaki is also the President of the PANACEA Corporation, a joint venture company with Great China International Holding Corporation since April 2015. Since 2006, Sasaki has served as Founder and CEO of Nikko Foods Corporation. Previously, he was affiliated Sumitomo trading subsidiary ST Agri Product Inc., Sun Trading Corporation, and Tamura Electric Corporation.
